Empo Health

Empo Health® is addressing the diabetic foot ulcers (DFUs) that affect 25% of all diabetic patients in their lifetime and lead to 150K amputations/year in the US ($80B+/yr in DFU healthcare spend). The FDA-listed Empo® Footprint in-home imaging scale and accompanying Empo® Remote Health Link patient monitoring service empower patients, podiatrists, and payors to detect early signs of ulcers and intervene at the right time, when it’s least invasive and most cost-effective.

Industry: Medical Device

Company Size: 11-50 employees